Instalab
logoInstalab

Vitamin D (1,25-dihydroxy)

Blood Test
Get a read on the active vitamin D hormone, beyond what a routine vitamin D test shows.
4.9 (3,740 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Calcitriol test?

This test is most useful if any of these apply to you.

Already Managing Kidney Issues
Your kidneys make this hormone, so a falling level can be one of the earliest signs your kidneys are not keeping up with mineral balance.
Investigating Calcium Swings
If your calcium has been bouncing around without explanation, this test helps pinpoint whether your active vitamin D pathway is part of the cause.
Taking Active Vitamin D Medication
If you are on calcitriol, alfacalcidol, or a similar drug, this reading shows how the medication and your body's own production are balancing out.
Living With Sarcoidosis or a Related Condition
Immune tissue in granulomatous diseases can make extra active vitamin D, pushing calcium up. Checking this hormone helps catch that pattern early.

About Vitamin D (1,25-dihydroxy)

If your calcium has been drifting up or down without an obvious cause, or your kidneys are not working as well as they used to, the form of vitamin D that actually does the work in your body is worth measuring directly. This test looks at calcitriol, the hormone your kidneys make from stored vitamin D, which decides how much calcium your gut absorbs and how your bones, blood vessels, and immune cells respond.

Most people only ever check the storage form of vitamin D, called 25(OH)D (25-hydroxyvitamin D). That tells you what is sitting in the bank. This test, 1,25(OH)2D (1,25-dihydroxyvitamin D), tells you what your body is actually spending. The two numbers can move in opposite directions, and that gap is where the interesting clinical information lives.

Active Hormone vs Storage Form

Vitamin D from sun or food first travels to the liver, where it becomes 25(OH)D. That is the form a standard vitamin D blood test measures. To do anything useful, 25(OH)D then has to travel to the kidneys, where an enzyme called CYP27B1 turns it into the active hormone 1,25(OH)2D. Some immune cells and other tissues can also make small amounts locally.

Your body keeps 1,25(OH)2D under tight hormonal control. Parathyroid hormone (PTH), calcium, phosphate, and a bone-derived hormone called FGF23 all push it up or down over the course of hours. Because of this, 1,25(OH)2D can stay in a normal range even when your stored 25(OH)D is low, which is exactly why 25(OH)D, not 1,25(OH)2D, is the right test for everyday vitamin D status.

So why measure it at all? Because in certain situations the active hormone tells you something the storage form cannot. When your kidneys lose the ability to make 1,25(OH)2D, when overactive immune tissue makes too much of it, or when a drug interferes with the FGF23 system, 1,25(OH)2D moves before anything else explains why. This is a specialized test for a specific question, not a routine vitamin D screen.

Kidney Disease and Mineral Balance

Your kidneys are the main factory for active vitamin D. As kidney function falls, 1,25(OH)2D production falls with it, often before standard kidney numbers look alarming. In a study of 1,099 adults with advanced kidney disease, lower plasma 1,25(OH)2D was linked to a higher risk of death and progression to dialysis, even after accounting for kidney function.

The heart suffers too. In 513 people with chronic kidney disease, lower 1,25(OH)2D was independently associated with a thicker, stiffer left heart chamber and worse relaxation of that chamber. The standard 25(OH)D test did not show the same pattern in this group. This is one of the clearest places where the active hormone reveals something the storage form misses.

Calcium, Bone, and Hyperparathyroidism

1,25(OH)2D is the main hormone telling your gut to absorb calcium. When calcium runs low, PTH rises and tells the kidneys to make more 1,25(OH)2D. When something pushes 1,25(OH)2D too high, calcium absorption climbs and PTH falls. Measuring 1,25(OH)2D alongside calcium and PTH helps locate where in this loop something is off.

In a large study of 2,783 middle-aged and older men, the combination of high 1,25(OH)2D with low 25(OH)D was linked to poorer bone outcomes than either reading alone. The pattern suggests a bone system working overtime to compensate, which is a different problem than simple vitamin D shortage. The two measurements together give you the phenotype, not just a status check.

When the Pattern Looks Backward

A common surprise: someone can have normal or low 25(OH)D but unusually high 1,25(OH)2D, or vice versa. This is not a paradox once you understand the framework. 1,25(OH)2D is a phenotype indicator, not a fuel gauge. High active hormone with low storage form often means your parathyroid system is working hard to compensate. Low active hormone with adequate storage often means the kidneys cannot keep up the conversion. The right interpretation depends on the whole panel, not the 1,25(OH)2D number in isolation.

Critical Illness and Prognosis

Inflammation, surgical stress, and serious infection drag 1,25(OH)2D down. In a study of 91 adults with sepsis, those who died within 30 days had significantly lower 1,25(OH)2D at admission. The standard 25(OH)D test, in the same patients, did not separate survivors from non-survivors.

Similar patterns show up in cardiac surgery (n=92) and in 508 people preparing for stem cell transplantation, where pre-procedure 1,25(OH)2D predicted one-year survival while 25(OH)D did not. This is why some hospital and transplant teams now check the active hormone before high-risk procedures. It is not a routine reading, but it carries weight in specific settings.

Muscle Strength

Vitamin D receptors live inside skeletal muscle fibers, and the active hormone is the form that binds them. In a study comparing the two forms of vitamin D in human muscle function, serum 1,25(OH)2D correlated more closely with lower-limb power and lean mass than 25(OH)D did. Storage form influenced muscle mostly through body fat, while the active hormone had a more direct link.

Hypertension and Cardiovascular Signals

The story for blood pressure is less tidy. In the PREVEND study of 5,066 adults, higher plasma 1,25(OH)2D was linked to a higher, not lower, risk of developing hypertension over time. This runs against the common assumption that more vitamin D is always better. Because 1,25(OH)2D is hormonally regulated, a high reading in an otherwise healthy person may reflect a system working harder to maintain balance, not a state of abundance. This is another reason single readings should not drive decisions in isolation.

Why One Reading Is Not Enough

1,25(OH)2D swings with PTH, calcium intake, hydration, illness, and kidney function. Lab measurement of it carries meaningful variation: newer automated assays show analytical imprecision of roughly 4 to 7%, while older assays ran 12 to 20%, and the natural biological variation within the same person is about 22%. That means a single number near a decision threshold is not reliable on its own. Get a baseline. If something looks off, retest in clinical stability, ideally with 25(OH)D, PTH, calcium, phosphate, and a marker of kidney function (creatinine or cystatin C) drawn at the same time.

If you have known kidney disease or are taking active vitamin D medications, retest at least annually and any time symptoms or other labs shift. If you started a supplement or a new medication that affects the FGF23 or phosphate system, give it a few weeks to settle, then retest. A trend across two or three readings will tell you something a single value cannot.

When Results Can Be Misleading

Several factors can shift a single 1,25(OH)2D reading without changing your underlying health:

  • Acute illness or recent surgery: inflammation and stress can drop 1,25(OH)2D within days. Levels seen during or shortly after an ICU stay, infection, or operation often do not reflect your stable baseline.
  • Recent intense exercise: strength training and high-intensity intervals can transiently lower 1,25(OH)2D immediately after a session, likely because muscle is using more of it. Moderate exercise can transiently raise it. Both effects fade within about 24 hours.
  • SGLT2 inhibitors: five days of canagliflozin (a common diabetes and kidney medication) lowered 1,25(OH)2D by about 10% in healthy volunteers by activating the FGF23 and phosphate axis. This is a real biological shift, but it does not necessarily indicate disease.
  • Active vitamin D medications: taking calcitriol, eldecalcitol, or alfacalcidol directly replaces what your body makes and suppresses your own production of 1,25(OH)2D. The lab number then reflects the drug, not your physiology.

What to Do With an Unexpected Result

An out-of-pattern 1,25(OH)2D is rarely actionable on its own. The next move is almost always to look at the full mineral picture. Pair an unexpected result with 25(OH)D, intact PTH, calcium, phosphate, and a kidney function marker (creatinine, cystatin C, or eGFR). The combination tells you whether the active hormone is high or low because of kidney function, parathyroid activity, an immune process making vitamin D outside the kidneys, or a drug effect.

If 1,25(OH)2D is high with high calcium and suppressed PTH, that pattern can suggest a granulomatous condition (such as sarcoidosis) or certain lymphomas making vitamin D outside the kidneys, and it warrants specialist input. If 1,25(OH)2D is low with reduced kidney function and rising PTH, the workup belongs with a nephrologist. If it is low with normal kidneys but ongoing infection or severe illness, the underlying condition usually needs attention first. A repeat reading once you are stable is more informative than chasing the original number.

What Moves This Biomarker

Evidence-backed interventions that affect your Calcitriol level

↓ Decrease
Take an active vitamin D analogue such as calcitriol or eldecalcitol
Active vitamin D drugs do the job that 1,25(OH)2D normally does, so your body responds by making less of its own. Measured 1,25(OH)2D often falls, which is the expected pharmacology, not a problem. In a 3-year randomized trial of 1,256 adults given 0.75 micrograms of eldecalcitol per day, the drug suppressed endogenous 1,25(OH)2D production and also reduced progression to type 2 diabetes. If you are on one of these medications, your 1,25(OH)2D reading reflects the drug, not your own production.
MedicationStrong Evidence
↑ Increase
Take cholecalciferol (vitamin D3) for low vitamin D in non-dialysis kidney disease
If you have non-dialysis chronic kidney disease and low vitamin D, high-dose cholecalciferol can restore your kidneys' ability to make active vitamin D, raising 1,25(OH)2D and lowering PTH. In an 8-week randomized trial of 52 kidney disease patients given 40,000 IU per week, 1,25(OH)2D rose significantly in non-dialysis participants. Hemodialysis patients showed no rise, because their kidneys can no longer carry out the conversion.
MedicationModerate Evidence
↑ Increase
Train aerobically or with high-intensity intervals for 12 weeks
Structured exercise reliably raises active vitamin D in healthy adults. In a randomized trial of 89 sedentary middle-aged adults, 12 weeks of WHO-recommended exercise, high-intensity intervals, or intervals plus electrical muscle stimulation all raised 1,25(OH)2D versus controls, independent of which program participants did. Gains in 1,25(OH)2D also tracked with improvements in fitness and memory.
ExerciseModerate Evidence

Frequently Asked Questions

References

17 studies
  1. Marckmann P, Agerskov H, Thineshkumar S, Bladbjerg E, Sidelmann J, Jespersen J, Nybo M, Rasmussen L, Hansen D, Scholze aNephrology Dialysis Transplantation2012
  2. Kawahara T, Suzuki G, Mizuno S, Inazu T, Kasagi F, Kawahara C, Okada Y, Tanaka YThe BMJ2022
  3. De-la-o a, Jurado-fasoli L, Castillo M, Gutierrez a, Amaro-gahete FSports Health2021
  4. Blau J, Bauman V, Conway E, Piaggi P, Walter M, Wright E, Bernstein S, Courville a, Collins M, Rother K, Taylor SJCI Insight2018
  5. Biancuzzo R, Clarke N, Reitz R, Travison T, Holick MJournal of Clinical Endocrinology and Metabolism2013